Apple has officially launched its Threads account, amassing nearly 5 million followers instantly. This move highlights its willingness to explore new social media avenues despite its strong presence on X.
Nike is bracing for a staggering $1 billion cost increase due to tariffs from Trump's trade war, prompting price hikes and a shift in manufacturing. As revenues plunge, can Nike turn things around?
Henrik Werdelin's new venture, Audos, aims to democratize entrepreneurship by providing AI tools to everyday entrepreneurs, helping them launch successful businesses without technical skills.
Nike announces that President Trump's tariffs may increase its costs by $1 billion this year, prompting the company to shift production away from China. Amidst fluctuating trade policies, what does this mean for sneaker prices?
New Balance is shaking up the sports industry by signing rising stars like Cooper Flagg and Coco Gauff. Discover how the brand is transforming its image and revenue strategy to compete with giants like Nike and Adidas!
A team of astronomers reveals that a fast radio burst detected last year originated from the long-dead NASA satellite Relay 2, sparking new possibilities in space signal study.
The upcoming wedding of Jeff Bezos and Lauren Sanchez in Venice is shrouded in secrecy and controversy, with protests looming over the lavish event planned for this week. Guests are sworn to silence as speculation runs wild about the details, venue, and high-profile attendees.
In a surprising move, Texas Governor Greg Abbott vetoed a bill that would have banned all THC consumables, allowing the thriving market of THC-infused products to continue flourishing in the state. This decision protects jobs and revenue while highlighting ongoing debates about marijuana regulation.
Astronomers have made a groundbreaking discovery by capturing a direct image of GJ504b, a distant exoplanet likened to Jupiter. This achievement showcases advanced technology and opens new avenues in exoplanet research.
Recent research suggests that psilocybin, the active compound in magic mushrooms, may alleviate depressive episodes in bipolar II disorder, showing promise without triggering mania. The trial found significant improvements among participants, indicating a potential new treatment avenue.
